These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1649571)

  • 1. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
    Averett DR; Koszalka GW; Fyfe JA; Roberts GB; Purifoy DJ; Krenitsky TA
    Antimicrob Agents Chemother; 1991 May; 35(5):851-7. PubMed ID: 1649571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells.
    Biron KK; de Miranda P; Burnette TC; Krenitsky TA
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2116-20. PubMed ID: 1722079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
    Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.
    de Miranda P; Burnette TC; Biron KK; Miller RL; Averett DR; Krenitsky TA
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2121-4. PubMed ID: 1662024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of the anti-varicella-zoster virus agent 6-methoxypurine arabinoside and its 2'-O-valerate prodrug into human erythrocytes.
    Prus KL; Heidenreich AC; Zimmerman TP
    Antimicrob Agents Chemother; 1992 Feb; 36(2):283-6. PubMed ID: 1318676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal toxicity of 6-methoxypurine arabinoside (ara-M). A new selective and potent inhibitor of varicella-zoster virus.
    Karaçorlu S; Peyman GA; Karaçorlu M; Dunlap W; Soike KF
    Retina; 1992; 12(3):261-4. PubMed ID: 1329170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
    Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
    Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ; Lauter CB; Bailey EJ; Lerner AM
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
    Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.
    Shigeta S; Mori S; Watanabe F; Takahashi K; Nagata T; Koike N; Wakayama T; Saneyoshi M
    Antivir Chem Chemother; 2002 Mar; 13(2):67-82. PubMed ID: 12238531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
    Gephart JF; Lerner AM
    Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
    Miller RL; Iltis JP; Rapp F
    IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug testing for activity against varicella-zoster virus in hairless guinea pigs.
    Myers MG; Stanberry LR
    Antiviral Res; 1991 May; 15(4):341-4. PubMed ID: 1659314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
    Balzarini J; McGuigan C
    J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of oxetanocins against varicella-zoster virus.
    Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.
    Bryson YJ; Connor JD
    Antimicrob Agents Chemother; 1976 Mar; 9(3):540-3. PubMed ID: 176937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
    Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.